-
MDCG 2022-5 Rev. 1 published on (MDR) borderline products: medical devices and medicinal products,
in Uncategorized
-
MDCG issued 2024-13 on regulatory status of EtO,
in Uncategorized
-
MDCG 2021-25 Rev.1 report issued on transitional provisions,
in Uncategorized
-
Current status MDR / IVDR Notified Bodies,
in Uncategorized
-
Call to medical device manufacturers: implement an effective PMS system,
in Uncategorized
-
MDCG issued 2024-11 on qualification of in vitro diagnostic medical devices,
in Uncategorized
-
MDCG 2021-4 Q&A on how to handle class D IVDs during transition to IVDR – revision 1,
in Uncategorized
-
Revision 2 of MDR and IVDR language requirements for manufacturers published,
in Uncategorized
-
All documents related to the MDR and IVDR amending Regulations,
in Uncategorized
-
Manufacturer’s Declaration in relation to Regulation (EU) 2024/1860,
in Uncategorized
